Literature DB >> 24462303

Bone and mineral disorders after kidney transplantation: therapeutic strategies.

Miklos Z Molnar1, Mohamed S Naser2, Connie M Rhee3, Kamyar Kalantar-Zadeh4, Suphamai Bunnapradist5.   

Abstract

Mineral and bone diseases (MBD) are common in patients with chronic kidney disease who undergo kidney transplantation. The incidence, types and severity of MBD vary according to the duration of chronic kidney disease, presence of comorbid conditions and intake of certain medications. Moreover, multiple types of pathology may be responsible for MBD. After successful reversal of uremia by kidney transplantation, many bone and mineral disorders improve, while immunosuppression, other medications, and new and existing comorbidities may result in new or worsening MBD. Chronic kidney disease is also common after kidney transplantation and may impact bone and mineral disease. In this article, we reviewed the prevalence, pathophysiology, and impact of MBD on post-transplant outcomes. We also discussed the diagnostic approach; immunosuppression management and potential treatment of MBD in kidney transplant recipients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24462303      PMCID: PMC5588857          DOI: 10.1016/j.trre.2013.12.003

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  72 in total

1.  Effect of paricalcitol on the urinary peptidome of kidney transplant patients.

Authors:  V Pérez; A Sánchez; B Bayés; M Navarro-Muñoz; R Lauzurica; M C Pastor; R Romero
Journal:  Transplant Proc       Date:  2010-10       Impact factor: 1.066

2.  Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism.

Authors:  M E Cho; Z Duan; C E Chamberlain; J C Reynolds; M S Ring; R B Mannon
Journal:  Transplant Proc       Date:  2010-11       Impact factor: 1.066

3.  Transplantation: An end to bone disease after renal transplantation?

Authors:  Vincent M Brandenburg; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2012-11-13       Impact factor: 28.314

4.  Bone disease in children and adolescents undergoing successful renal transplantation.

Authors:  C P Sanchez; I B Salusky; B D Kuizon; J A Ramirez; B Gales; R B Ettenger; W G Goodman
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

5.  Effect of ibandronate on bone loss and renal function after kidney transplantation.

Authors:  Wolfgang Grotz; Christian Nagel; Daria Poeschel; Markus Cybulla; Karl-Georg Petersen; Markus Uhl; Christoph Strey; Günter Kirste; Manfred Olschewski; Achim Reichelt; Lars Christian Rump
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

6.  The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.

Authors:  Eugénie C H van den Ham; Jeroen P Kooman; Maarten L Christiaans; Johannes P van Hooff
Journal:  Transpl Int       Date:  2003-01-18       Impact factor: 3.782

7.  Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.

Authors:  Carlos Bergua; José-Vicente Torregrosa; David Fuster; Alex Gutierrez-Dalmau; Federico Oppenheimer; José M Campistol
Journal:  Transplantation       Date:  2008-08-15       Impact factor: 4.939

8.  Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients.

Authors:  G Lehmann; U Ott; G Stein; T Steiner; G Wolf
Journal:  Transplant Proc       Date:  2007-12       Impact factor: 1.066

9.  Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

Authors:  M Wang; G Hercz; D J Sherrard; N A Maloney; G V Segre; Y Pei
Journal:  Am J Kidney Dis       Date:  1995-11       Impact factor: 8.860

10.  Use of alendronate sodium (Fosamax) to ameliorate osteoporosis in renal transplant patients: a case-control study.

Authors:  Wen-Hung Huang; Shen-Yang Lee; Cheng-Hao Weng; Ping-Chin Lai
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more
  7 in total

1.  A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation.

Authors:  Mahmut Ilker Yilmaz; Alper Sonmez; Mutlu Saglam; Tuncer Cayci; Selim Kilic; Hilmi Umut Unal; Murat Karaman; Hakki Cetinkaya; Tayfun Eyileten; Mahmut Gok; Yusuf Oguz; Abdulgaffar Vural; Francesca Mallamaci; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 8.237

Review 2.  CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.

Authors:  A Prytuła; K Cransberg; A Raes
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

Review 3.  Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.

Authors:  Gong-bin Lan; Xu-biao Xie; Long-kai Peng; Lei Liu; Lei Song; He-long Dai
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

4.  The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.

Authors:  Mariel J Hernandez; Luciene M Dos Reis; Igor D Marques; Maria J Araujo; Cesar A M Truyts; Ivone B Oliveira; Fellype C Barreto; Elias David-Neto; Melani R Custodio; Rosa M Moyses; Ezequiel Bellorin-Font; Vanda Jorgetti
Journal:  PLoS One       Date:  2018-05-25       Impact factor: 3.240

5.  The Effects of Immunosuppressive Treatment during Pregnancy on the Levels of Potassium, Iron, Chromium, Zinc, Aluminum, Sodium and Molybdenum in Hard Tissues of Female Rats and Their Offspring.

Authors:  Daniel Styburski; Wojciech Żwierełło; Marta Skórka-Majewicz; Marta Goschorska; Irena Baranowska-Bosiacka; Joanna Kabat-Koperska; Dariusz Chlubek; Izabela Gutowska
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

6.  Mineral and bone disorder after kidney transplantation (KTx).

Authors:  Carolina Lara Neves; Igor Dernizate B Marques; Melani Ribeiro Custódio
Journal:  J Bras Nefrol       Date:  2021-12-03

7.  A Pilot Trial to Examine the Changes in Carotid Arterial Inflammation in Renal Transplant Recipients as Assessed by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography Computed Tomography (PET/CT).

Authors:  Hye Eun Yoon; Yaeni Kim; Sang Dong Kim; Jin Kyoung Oh; Yong-An Chung; Seok Joon Shin; Chul Woo Yang; Suk Min Seo
Journal:  Ann Transplant       Date:  2018-06-15       Impact factor: 1.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.